Radiopharmaceuticals: Technologies and Global Markets

  • ID: 4013491
  • Report
  • Region: Global
  • 189 Pages
  • BCC Research
1 of 5
The Global Market Radiopharmaceuticals Market is Expected to Increase from Nearly $6.5 Billion in 2016 to $11.6 Billion in 2021 at a CAGR of 12.4%

FEATURED COMPANIES

  • Alliance Medical Group
  • Bayer Pharma AG
  • Cardinal Health Inc.
  • Iba Molecular
  • Jubilant Draximage Inc.
  • Ntp Radioisotopes Soc Ltd
  • MORE

The global market radiopharmaceuticals were valued at nearly $5.1 billion and $5.7 billion in 2014 and 2015, respectively. This market is expected to increase from nearly $6.5 billion in 2016 to $11.6 billion in 2021 at a compound annual growth rate (CAGR) of 12.4% for 2016-2021.

This report provides:

  • An overview of the global market for radiopharmaceuticals and related technologies.
  • Analyses of global market trends, with data from 2014 and 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
  • Details concerning the regulatory environment and the impacts of government on the market.
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of leading companies in the industry.

This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.

In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.

This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alliance Medical Group
  • Bayer Pharma AG
  • Cardinal Health Inc.
  • Iba Molecular
  • Jubilant Draximage Inc.
  • Ntp Radioisotopes Soc Ltd
  • MORE

1: Introduction

  • Study Objectives
  • Reasons For Doing This Study
  • Contributions Of The Study And Intended Audience
  • Scope Of The Study
  • Methodology
  • Information Sources

2: Executive Summary

  • Table Summary : Global Market For Radiopharmaceuticals, By Region, Through 2021
  • Figure Summary : Global Market For Radiopharmaceuticals, By Region, 2014-2021

3: Overview

  • Uses Of Radiopharmaceuticals
  • Definitions
  • History And Background
  • Origin Of Radionuclides
  • Commonly Used Radionuclides In Medicine
  • Preparation Of Radiopharmaceuticals
  • Applications Of Radiopharmaceuticals
  • Advantages And Disadvantages Of Radiopharmaceuticals

4: Regulatory Aspects

  • New Drug Approvals And Applications
  • Approvals For Radionuclide Brachytherapy Sources
  • Safety Alerts
  • Adverse Event Reporting
  • Drug Shortages

5: New Developments

  • Pipeline Products
  • Other Significant New Developments In Radiopharmaceuticals

6: Market Analysis

  • Market By Radiopharmaceutical Type
  • Diagnostic Radiopharmaceuticals Market By Region
  • Therapeutic Radiopharmaceuticals Market By Region
  • Radiopharmaceuticals Market By Production Method

7: Industry Structure

  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals

8: Patent Analysis

  • Patents By Year
  • Patents By Type Of Radionuclide
  • Patents By Company
  • Patents By Country
  • Patents By Assignee Type

9: Current Situation

  • Factors Affecting The Radiopharmaceuticals Market
  • Collaborations, Mergers And Acquisitions

10: Company Profiles

  • Actinium Pharmaceuticals Inc.
  • Advanced Accelerator Applications SA
  • Advanced Medical Isotope Corp.
  • Alliance Medical Group
  • Alseres Pharmaceuticals Inc.
  • Australian Nuclear Association And Technology Organization
  • Aytu Bioscience Inc.
  • Bard Medical
  • Bayer Pharma AG
  • Blue Earth Diagnostics Ltd.
  • Board Of Radiation And Isotope Technology
  • Bracco Diagnostic Inc.
  • Btg International Ltd.
  • Cardinal Health Inc.
  • Eli Lilly And Company
  • Fujifilm Ri Pharma Co. Ltd.
  • Ge Healthcare
  • Iba Molecular
  • Isoray Medical Inc.
  • Iso-Tex Diagnostics Inc.
  • Jubilant Draximage Inc.
  • Lantheus Medical Imaging Inc.
  • Mallinckrodt Plc
  • National Centre For Nuclear Research Polatom
  • National Institute For Radioelements (IRE)
  • Navidea Biopharmaceuticals Inc.
  • Nordion Inc.
  • Ntp Radioisotopes Soc Ltd
  • Pharmalucence Inc.
  • Piramal Imaging SA
  • Siemens Healthcare GMBH
  • Spectrum Pharmaceuticals Inc.
  • Triad Isotopes Inc.
  • Zevacor Molecular

11: Abbreviations

  • Table 59 : Abbreviations

List Of Tables

Summary Table : Global Market For Radiopharmaceuticals, By Region, Through 2021
Table 1 : Milestones Of The Discovery Of Radioactivity And Nuclear Medicine
Table 2 : Common Cyclotron-Produced Radionuclides/Radioisotopes
Table 3 : Common Nuclear Reactor-Produced Radionuclides/Radioisotopes
Table 4 : Common Radionuclide Pairs In Radionuclide Generators
Table 5 : Common Isotopes Used In Diagnostic Radiopharmaceutical Development
Table 6 : Selected Commercially Approved Diagnostic Radiopharmaceuticals
Table 7 : Common Isotopses Used In Therapeutic Radiopharmaceutical Development
Table 8 : Selected Commercially Approved Therapeutic Radiopharmaceuticals
Table 9 : Advantages And Disadvantages Of Alpha Emitters
Table 10 : Advantages And Disadvantages Of Beta Emitters
Table 11 : Commonly Used Radionuclides (Radiation Sources) For Brachytherapy
Table 12 : Advantages And Disadvantages Of Brachytherapy
Table 13 : Advantages And Disadvantages Of Radiopharmaceuticals
Table 14 : Approvals Of New Drug Applications For Radiopharmaceuticals, From January 2014 To May 2016
Table 15 : Approvals Of Abbreviated New Drug Applications For Radiopharmaceuticals, From January 2014 To May 2016
Table 16 : 510K Approvals For Radionuclide Brachytherapy Sources, January 2014-May 2016
Table 17 : Safety Alerts Issued For Radiopharmaceuticals, From January 2014-May 2016
Table 18 : Adverse Event Reporting For Radionuclide Brachytherapy Sources, From January 2014-May 2016
Table 19 : Radiopharmaceutical Shortages, Through May 2016
Table 20 : Clinical Trials For Radiopharmaceuticals, Through May 2016
Table 21 : Global Market For Radiopharmaceuticals, By Type, Through 2021
Table 22 : Global Market Shares Of Radiopharmaceuticals, By Type, 2015
Table 23 : Global Market For Diagnostic Radiopharmaceuticals, By Type Of Diagnostic Test, Through 2021
Table 24 : Global Market For Pet Radiopharmaceuticals, By Region, Through 2021
Table 25 : Global Market For Pet Radiopharmaceuticals, By Type Of Radionuclide, Through 2021
Table 26 : Global Market For Spect Radiopharmaceuticals, By Region, Through 2021
Table 27 : Global Market For Spect Radiopharmaceuticals, By Type Of Radionuclide, Through 2021
Table 28 : Global Market For Other Diagnostic Radiopharmaceuticals, By Region, Through 2021
Table 29 : Global Market For Other Diagnostic Radiopharmaceuticals, By Type Of Radionuclide, Through 2021
Table 30 : Market Shares Of Diagnostic Radiopharmaceuticals, By Type Of Diagnostic Test, 2015
Table 31 : Global Market For Therapeutic Radiopharmaceuticals, By Type, Through 2021
Table 32 : Global Market For Alpha Emitters, By Region, Through 2021
Table 33 : Global Market For Alpha Emitters, By Type Of Radionuclide, Through 2021
Table 34 : Global Market For Beta Emitters, By Region, Through 2021
Table 35 : Global Market For Beta Emitters, By Type Of Radionuclide, Through 2021
Table 36 : Global Market For Ldr Brachytherapy Seeds, By Region, Through 2021
Table 37 : Global Market For Brachytherapy Seeds, By Type Of Radionuclide, Through 2021
Table 38 : Market Shares Of Therapeutic Radiopharmaceuticals, By Type, 2015
Table 39 : Global Market For Diagnostic Radiopharmaceuticals, By Region, Through 2021
Table 40 : Market Shares Of Diagnostic Radiopharmaceuticals, By Region, 2015
Table 41 : Global Market For Therapeutic Radiopharmaceuticals, By Region, Through 2021
Table 42 : Market Shares Of Therapeutic Radiopharmaceuticals, By Region, 2015
Table 43 : Global Market For Radiopharmaceuticals, By Production Method, Through 2021
Table 44 : Market Shares Of Radiopharmaceuticals, By Production Method, 2015
Table 45 : Leading Manufacturers/Suppliers Of Pet Radiopharmaceuticals, 2015
Table 46 : Market Shares Of Manufacturers/Suppliers Of Pet Radiopharmaceuticals, 2015
Table 47 : Leading Manufacturers/Suppliers Of Spect Radiopharmaceuticals, 2015
Table 48 : Market Shares Of Manufacturers/Suppliers Of Spect Radiopharmaceuticals, 2015
Table 49 : Leading Manufacturers/Suppliers Of Other Diagnostic Radiopharmaceuticals, 2015
Table 50 : Market Shares Of Manufacturers/Suppliers Of Other Diagnostic Radiopharmaceuticals, 2015
Table 51 : Leading Manufacturers/Suppliers Of Therapeutic Radiopharmaceuticals, 2015
Table 52 : Market Shares Of Manufacturers/Suppliers Of Therapeutic Radiopharmaceuticals, 2015
Table 53 : Number Of Significant Patents For Radiopharmaceuticals/ Radionuclides, January 2014-May 2016
Table 54 : Patents By Type Of Radionuclide, January 2014-May 2016
Table 55 : Number Of Patents By Company, January 2014-May 2016
Table 56 : Number Of Patents By Country, January 2014-May 2016
Table 57 : Patent Shares By Country, January 2014-May 2016
Table 58 : Number Of Patents By Assignee Type, January 2014 -May 2016
Table 59 : Abbreviations

List Of Figures

Summary Figure : Global Market For Radiopharmaceuticals, By Region, 2014-2021
Figure 1 : Global Market For Radiopharmaceuticals, By Type, 2014-2021
Figure 2 : Global Market Shares Of Radiopharmaceuticals, By Type, 2015
Figure 3 : Global Market For Diagnostic Radiopharmaceuticals, By Type Of Diagnostic Test, 2014-2021
Figure 4 : Global Market For Pet Radiopharmaceuticals, By Region, 2014-2021
Figure 5 : Global Market For Pet Radiopharmaceuticals, By Type Of Radionuclide, 2014-2021
Figure 6 : Global Market For Spect Radiopharmaceuticals, By Region, 2014-2021
Figure 7 : Global Market For Spect Radiopharmaceuticals, By Type Of Radionuclide, 2014-2021
Figure 8 : Global Market For Other Diagnostic Radiopharmaceuticals, By Region, 2014-2021
Figure 9 : Global Market For Other Diagnostic Radiopharmaceuticals, By Type Of Radionuclide, 2014-2021
Figure 10 : Market Shares Of Diagnostic Radiopharmaceuticals, By Type Of Diagnostic Test, 2015
Figure 11 : Global Market For Therapeutic Radiopharmaceuticals, By Type, 2014-2021
Figure 12 : Global Market For Alpha Emitters, By Region, 2014-2021
Figure 13 : Global Market For Alpha Emitters, By Type Of Radionuclide, 2014-2021
Figure 14 : Global Market For Beta Emitters, By Region, 2014-2021
Figure 15 : Global Market For Beta Emitters, By Type Of Radionuclide, 2014-2021
Figure 16 : Global Market For Ldr Brachytherapy Seeds, By Region, 2014-2021
Figure 17 : Global Market For Brachytherapy Seeds, By Type Of Radionuclide, 2014-2021
Figure 18 : Market Shares Of Therapeutic Radiopharmaceuticals, By Type, 2015
Figure 19 : Global Market For Diagnostic Radiopharmaceuticals, By Region, 2014-2021
Figure 20 : Market Shares Of Diagnostic Radiopharmaceuticals, By Region, 2015
Figure 21 : Global Market For Therapeutic Radiopharmaceuticals, By Region, 2014-2021
Figure 22 : Market Shares Of Therapeutic Radiopharmaceuticals, By Region, 2015
Figure 23 : Global Market For Radiopharmaceuticals, By Production Method, 2014-2021
Figure 24 : Market Shares Of Radiopharmaceuticals, By Production Method, 2015
Figure 25 : Market Shares Of Manufacturers/Suppliers Of Pet Radiopharmaceuticals, 2015
Figure 26 : Market Shares Of Manufacturers/Suppliers Of Spect Radiopharmaceuticals, 2015
Figure 27 : Market Shares Of Manufacturers/Suppliers Of Other Diagnostic Radiopharmaceuticals, 2015
Figure 28 : Market Shares Of Manufacturers/Suppliers Of Therapeutic Radiopharmaceuticals, 2015
Figure 29 : Number Of Significant Patents For Radiopharmacauticals/ Radionuclides, From January 2014-May 2016
Figure 30 : Patents By Type Of Radionuclide, January 2014-May 2016
Figure 31 : Number Of Patents By Country, January 2014-May 2016
Figure 32 : Patent Shares By Country, January 2014-May 2016
Figure 33 : Number Of Patents By Assignee Type, January 2014-May 2016

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Actinium Pharmaceuticals Inc.
  • Advanced Accelerator Applications SA
  • Advanced Medical Isotope Corp.
  • Alliance Medical Group
  • Alseres Pharmaceuticals Inc.
  • Australian Nuclear Association And Technology Organization
  • Aytu Bioscience Inc.
  • Bard Medical
  • Bayer Pharma AG
  • Blue Earth Diagnostics Ltd.
  • Board Of Radiation And Isotope Technology
  • Bracco Diagnostic Inc.
  • Btg International Ltd.
  • Cardinal Health Inc.
  • Eli Lilly And Company
  • Fujifilm Ri Pharma Co. Ltd.
  • Ge Healthcare
  • Iba Molecular
  • Isoray Medical Inc.
  • Iso-Tex Diagnostics Inc.
  • Jubilant Draximage Inc.
  • Lantheus Medical Imaging Inc.
  • Mallinckrodt Plc
  • National Centre For Nuclear Research Polatom
  • National Institute For Radioelements (IRE)
  • Navidea Biopharmaceuticals Inc.
  • Nordion Inc.
  • Ntp Radioisotopes Soc Ltd
  • Pharmalucence Inc.
  • Piramal Imaging SA
  • Siemens Healthcare GMBH
  • Spectrum Pharmaceuticals Inc.
  • Triad Isotopes Inc.
  • Zevacor Molecular
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll